Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA GLENMARK PHARMA AUROBINDO PHARMA/
GLENMARK PHARMA
 
P/E (TTM) x 14.3 12.2 117.5% View Chart
P/BV x 1.4 1.6 90.9% View Chart
Dividend Yield % 1.5 0.6 235.8%  

Financials

 AUROBINDO PHARMA   GLENMARK PHARMA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-22
GLENMARK PHARMA
Mar-21
AUROBINDO PHARMA/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,064573 185.7%   
Low Rs584195 299.1%   
Sales per share (Unadj.) Rs400.3387.8 103.2%  
Earnings per share (Unadj.) Rs45.734.4 133.0%  
Cash flow per share (Unadj.) Rs64.950.1 129.6%  
Dividends per share (Unadj.) Rs9.002.50 360.0%  
Avg Dividend yield %1.10.7 167.8%  
Book value per share (Unadj.) Rs419.4249.6 168.0%  
Shares outstanding (eoy) m585.94282.17 207.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.11.0 207.9%   
Avg P/E ratio x18.011.2 161.4%  
P/CF ratio (eoy) x12.77.7 165.5%  
Price / Book Value ratio x2.01.5 127.7%  
Dividend payout %19.77.3 270.8%   
Avg Mkt Cap Rs m482,799108,353 445.6%   
No. of employees `000NANA-   
Total wages/salary Rs m34,50923,437 147.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m234,555109,439 214.3%  
Other income Rs m3,226502 642.4%   
Total revenues Rs m237,781109,941 216.3%   
Gross profit Rs m42,56621,289 199.9%  
Depreciation Rs m11,2654,436 254.0%   
Interest Rs m4863,531 13.8%   
Profit before tax Rs m34,04013,825 246.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2564,124 176.0%   
Profit after tax Rs m26,7849,701 276.1%  
Gross profit margin %18.119.5 93.3%  
Effective tax rate %21.329.8 71.5%   
Net profit margin %11.48.9 128.8%  
BALANCE SHEET DATA
Current assets Rs m181,22773,596 246.2%   
Current liabilities Rs m81,56042,010 194.1%   
Net working cap to sales %42.528.9 147.2%  
Current ratio x2.21.8 126.8%  
Inventory Days Days257 377.9%  
Debtors Days Days6286 72.8%  
Net fixed assets Rs m155,10467,093 231.2%   
Share capital Rs m586282 207.6%   
"Free" reserves Rs m245,17470,148 349.5%   
Net worth Rs m245,76070,430 348.9%   
Long term debt Rs m2,49238,888 6.4%   
Total assets Rs m336,331140,689 239.1%  
Interest coverage x71.04.9 1,444.2%   
Debt to equity ratio x00.6 1.8%  
Sales to assets ratio x0.70.8 89.7%   
Return on assets %8.19.4 86.2%  
Return on equity %10.913.8 79.1%  
Return on capital %13.915.9 87.6%  
Exports to sales %31.10-   
Imports to sales %11.90-   
Exports (fob) Rs m72,862NA-   
Imports (cif) Rs m27,965NA-   
Fx inflow Rs m77,24535,753 216.1%   
Fx outflow Rs m31,52412,023 262.2%   
Net fx Rs m45,72123,729 192.7%   
CASH FLOW
From Operations Rs m50,16511,312 443.5%  
From Investments Rs m-32,116-6,752 475.6%  
From Financial Activity Rs m-29,693-4,418 672.1%  
Net Cashflow Rs m-11,674278 -4,196.3%  

Share Holding

Indian Promoters % 48.8 46.7 104.5%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 38.0 34.7 109.4%  
FIIs % 20.7 24.2 85.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 53.4 90.3%  
Shareholders   359,684 312,473 115.1%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    ZYDUS LIFESCIENCES    LUPIN    



Today's Market

Sensex Zooms 130 Points, Nifty Ends Above 17,600; Financial and IT Stocks Rally(Closing)

Indian benchmark indices ended on a positive note amid a highly volatile session. This was on the back of metal stocks along with banking and financials.